Tripathy Talks Genomics, Targeted Treatments, and Smart Trial Designs in Breast Cancer

In our exclusive interview, Debu Tripathy, MD, considers the biological and long-term outcome variability of HR-positive, HER2-negative breast cancer and details the research that is being done to develop personalized treatment approaches.